ELIZABETH TRENTACOST counsels life sciences, food, and consumer products companies on a broad range of Food and Drug Administration (FDA) regulatory, compliance, enforcement, and strategic matters. She routinely advises on issues related to product development and applications, clinical research, inspections, promotional review matters, interacting with FDA, policy advocacy, and business transactions involving FDA-regulated companies. Prior to joining Arnold & Porter, she spent several years as a Regulatory Counsel in the Office of Regulatory Policy in FDA’s Center for Drug Evaluation and Research. At FDA, she was involved in a wide variety of policy issues involving drug approvals, responded to citizen petitions, developed guidance for industry, and counseled on matters relating to Hatch-Waxman marketing exclusivities. Previously, Trentacost worked at a law firm in Washington, D.C. where she focused on international trade investigations and appellate litigation.